CN105232060A - Early warning system based on independent risk factor combinatory screening - Google Patents
Early warning system based on independent risk factor combinatory screening Download PDFInfo
- Publication number
- CN105232060A CN105232060A CN201510548703.2A CN201510548703A CN105232060A CN 105232060 A CN105232060 A CN 105232060A CN 201510548703 A CN201510548703 A CN 201510548703A CN 105232060 A CN105232060 A CN 105232060A
- Authority
- CN
- China
- Prior art keywords
- blood
- examination
- module
- user
- detected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention discloses an early warning system based on independent risk factor combinatory screening. In the system, an input module of the system is used for inputting personal basic information of a user to be detected, a selector module is used by the user to be detected, to select a blood test scheme to be carried out, a blood sampling device is used for collecting blood of the user to be detected, a blood tester is used for detecting type of the chosen blood test scheme for the collected blood of the user to be detected, a data processing module is used for receiving blood test results transmitted by the blood tester, comparing the blood test results with pre-stored reference data, and transmitting comparison results and conclusions to a results processing module after comparison is complete, and the results processing module is used for processing the received comparison results and conclusions, and transmitting the processed results to a results output module for displaying. The system and method carry out detection in a most convenient and feasible manner, attack rate of serious diseases and death rate are decreased, and the cost is low.
Description
Technical field
The present invention relates to medical treatment and technical field of electronic communication, particularly a kind of early warning system based on the examination of independent risk combinations of factors.
Background technology
Present Hospital Physical Examination is general health health check-up, does not have the Forewarn evaluation of special major disease, and major disease early warning examination belongs to preventive medicine category, and hospital is treatment mechanism, the Bu Shi disease-prevention institutions, itself does not bear the prevention screening and assessing before suffering from major disease.Both just had MEC, to the detection methods of tumor nothing more than following several, discovery be also middle and advanced stage, instead of in early days, above detection all can not find the minimal neoplastic (infantile tumour) of diameter < 0.8cm.
Present private MEC, be also have a medical check-up based on common, only several, tumor mostly is cancer middle and advanced stage index, as AFP, CEA, CA125, CA199 etc.Even if there is indivedual early stage index, also not with the combination of other index, rate of sifting out is lower, easily reduces sensitivity, leaks sieve rate and increases, assessment objectivity and accuracy poor.
Summary of the invention
For above-mentioned technical problem, the invention provides that one is made a distinction between the important and the lesser one, rate of sifting out is high, simple to operate, simultaneously the early warning system based on the examination of independent risk combinations of factors that significantly reduces of inspection fee.
For solving the problems of the technologies described above, the technical solution used in the present invention is: provide a kind of early warning system based on the examination of independent risk combinations of factors, comprises input module, selects module, blood-taking device, blood examination device, data processing module, result treatment module and result output module;
Described input module, for inputting the individual essential information of user to be detected;
Described selection module, selects the blood examination scheme that will carry out for user to be detected;
Described blood-taking device, for gathering the blood of user to be detected;
Described blood examination device, for detecting according to the blood examination scheme selected the user's blood to be detected gathered;
Described data processing module, for receiving the blood examination result that described blood examination device transmits, comparing the reference data of blood examination result in conjunction with individual essential information and pre-stored, comparison result and conclusion is delivered to described result treatment module;
Described result treatment module is used for the comparison result received and conclusion is classified and stores processor, and the result after process is delivered to described result output module and shows.
The present invention is owing to adopting above technical scheme, its technique effect reached is: the early warning system based on the examination of independent risk combinations of factors provided by the invention, break existing hospital routine physical examination finds evening situation to major disease, life-and-death morning is looked into project, with the most convenient, the most feasible mode detects, lower the M & M of major disease, any injury is there is not to client's health in this early warning system and method when detecting, there is good repeatability, both can carry out qualitative when detecting simultaneously, can also carry out quantitatively, and the expense detected detects reduce more than 60% than going hospital and MEC to do a complete set of iconography or blood biochemical analysis, more easily accepted by the common people.
On the basis of technique scheme, the present invention can also do following improvement:
More preferably, in technique scheme, described blood examination device screens the user's blood to be detected gathered, filter out the extreme early mark in blood, by the extreme early mark filtered out respectively with in the blood examination scheme of described selection model choice, the mark in late period combines, and Real-Time Monitoring combine after the change of generation of extreme early mark.
The beneficial effect of above-mentioned further scheme is adopted to be: when detecting blood, by extreme early mark with corresponding in, late-stage markers thing combines, specific aim is had more when disease detection, in relevant to other, late-stage markers thing combines, to " healthy population " and before suffering from cancer the client of disease detect, this compound mode can Timeliness coverage to the sudden change of respective cells in " healthy population ", it is instructed to check further or preventative blocking-up, especially disease before cancer is cancerated or cancer stricken middle and advanced stage and the client do not known, also the probability sifted out can be increased, reduce because of terminal cancer TCSA variation or be closed, the illusion that early stage index is likely negative.By rational combination, really accomplish that early cancer risk improves the rate of sifting out as far as possible to more than 95%, the Advanced cancers patient do not discovered oneself does not also omit as far as possible.
More preferably, in technique scheme, the reference data of blood examination normal value for different blood examination scheme and blood examination exceptional value is previously stored with in described data processing module, described reference data graphically stores, and draws the conclusion of excessive risk, low-risk or devoid of risk in conjunction with the data that the transmission of described blood examination device comes.
The beneficial effect of above-mentioned further scheme is adopted to be: the correction data of pre-stored in graphical form, it is more pointed when the data next with the transmission of blood examination device are compared, further increase degree of accuracy during comparison, the risk assessment for the later stage provides foundation more accurately.
More preferably, in technique scheme, in described data processing module, be previously stored with the therapeutic scheme for different risk conclusion, subsidiary corresponding therapeutic scheme while transmitting conclusion to described result treatment module.
Adopt the beneficial effect of above-mentioned further scheme to be: the setting of therapeutic scheme, well treat foundation for user to be detected provides, further, therapeutic scheme is formulated in conjunction with patient's own situation science, well avoids the deterioration of user's state of an illness to be detected.
More preferably, in technique scheme, the data after the personal information of user to be detected and classification store by described data processing module are integrated, and the data after integrating are passed to described result treatment module.
Adopt the beneficial effect of above-mentioned further scheme to be: by the personal information of user and blood examination result integrate, be equivalent to addition of unique identifier to blood examination result, improve the accuracy and unique degree that convey to user profile.
More preferably, in technique scheme, clear data form is pre-stored with in described result treatment module, the therapeutic scheme of the data obtained from described data processing module, conclusion and correspondence is filled into position corresponding in described clear data form by described result treatment module, and is shown by the result Output of for ms after process to described result output module.
The beneficial effect of above-mentioned further scheme is adopted to be: to store the quality scheme of data, conclusion and correspondence that data processing module transmission comes in table form, make result treatment module more convenient when carrying out date processing, and store in table form, also more directly perceived when checking.
More preferably, in technique scheme, the blood volume of the user to be detected of collection is 5ml.
The beneficial effect of above-mentioned further scheme is adopted to be: the blood only gathering 5ml, reduce the feared state of mind of user to be detected to a large amount of blood sampling to a certain extent, further, gather the determination that the blood volume of 5ml can realize the Treatment and diagnosis scheme to major disease, also embody and detect and the superiority of warning aspect in major disease based on the early warning system of independent risk combinations of factors examination and method.
More preferably, in technique scheme, described individual essential information comprises name, sex, age and history of disease.
The beneficial effect of above-mentioned further scheme is adopted to be: name, the sex and age of typing user to be detected when typing individual essential information, specify that the corresponding relation between blood examination result and user to be measured, and the input of history of disease, the determination for anaphase scheme provides good foundation.
More preferably, in technique scheme, described result output module is medical display.
The beneficial effect of above-mentioned further scheme is adopted to be: to select special medical display, more complete when blood examination data and personal information when showing, and service life is also longer.
More preferably, in technique scheme, also comprise print module, the result form obtained from described result output module prints by described print module.
The beneficial effect of above-mentioned further scheme is adopted to be: print module prints receiving from result output module the data come, more more directly perceived than what show on result output module, also facilitating user to be detected takes the testing result of papery and therapeutic scheme home further treatment simultaneously.And also facilitate the storage of mechanism to user's case to be detected, papery storage is higher than Electronic saving degree of safety.
Accompanying drawing explanation
Below in conjunction with accompanying drawing, the invention will be further described:
Fig. 1 is the frame diagram of the disease warning system that the present invention is based on the examination of independent risk combinations of factors.
Detailed description of the invention
As shown in Figure 1, early warning system based on the examination of independent risk combinations of factors provided by the invention, comprise input module, select module, blood-taking device, blood examination device, data processing module, result treatment module and result output module, input module, for inputting the individual essential information of user to be detected, select module, the blood examination scheme that will carry out is selected for user to be detected, blood-taking device, for gathering the blood of user to be detected, blood examination device, for detecting according to the blood examination scheme selected the user's blood to be detected gathered, data processing module, for receiving the blood examination result that blood examination device transmits, the reference data of blood examination result in conjunction with individual essential information and pre-stored is compared, comparison result and conclusion are delivered to result treatment module, result treatment module is used for the comparison result received and conclusion is classified and stores processor, and the result after process is delivered to result output module and shows.
As a kind of embodiment, blood examination device screens the user's blood to be detected gathered, filter out the extreme early mark in blood, by the extreme early mark filtered out respectively with select in the blood examination scheme of model choice, the mark in late period combines, and Real-Time Monitoring combine after the change of generation of extreme early mark.When detecting blood, by extreme early mark with corresponding in, late-stage markers thing combines, specific aim is had more when disease detection, in relevant to other, late-stage markers thing combines, to " healthy population " and before suffering from cancer the client of disease detect, this compound mode can Timeliness coverage to the sudden change of respective cells in " healthy population ", it is instructed to check further or preventative blocking-up, especially disease before cancer is cancerated or cancer stricken middle and advanced stage and the client do not known, also the probability sifted out can be increased, reduce because of terminal cancer TCSA variation or be closed, the illusion that early stage index is likely negative.By rational combination, really accomplish that early cancer risk improves the rate of sifting out as far as possible to more than 95%, the Advanced cancers patient do not discovered oneself does not also omit as far as possible.
As a kind of embodiment, the reference data of blood examination normal value for different blood examination scheme and blood examination exceptional value is previously stored with in data processing module, reference data graphically stores, and draws the conclusion of excessive risk, low-risk or devoid of risk in conjunction with the data that the transmission of blood examination device comes.The correction data of pre-stored in graphical form, more pointed when the data next with the transmission of blood examination device are compared, further increase degree of accuracy during comparison, the risk assessment for the later stage provides foundation more accurately.
As a kind of embodiment, in data processing module, be previously stored with the therapeutic scheme for different risk conclusion, subsidiary corresponding therapeutic scheme while transmitting conclusion to result treatment module.The setting of therapeutic scheme, well treats foundation for user to be detected provides, and further, therapeutic scheme is formulated in conjunction with patient's own situation science, well avoids the deterioration of user's state of an illness to be detected.
As a kind of embodiment, the data after the personal information of user to be detected and classification store by data processing module are integrated, and the data after integrating are passed to result treatment module.By the personal information of user and blood examination result integrate, be equivalent to addition of unique identifier to blood examination result, improve the accuracy and unique degree that convey to user profile.
As a kind of embodiment, clear data form is pre-stored with in result treatment module, the therapeutic scheme of the data obtained from data processing module, conclusion and correspondence is filled into position corresponding in clear data form by result treatment module, and is shown to result output module by the result Output of for ms after process.In table form the quality scheme of data, conclusion and correspondence that data processing module transmission comes is stored, make result treatment module more convenient when carrying out date processing, and store in table form, also more directly perceived when checking.
As a kind of embodiment, the blood volume of the user to be detected of collection is 5ml.Only gather the blood of 5ml, reduce the feared state of mind of user to be detected to a large amount of blood sampling to a certain extent, further, gather the determination that the blood volume of 5ml can realize the Treatment and diagnosis scheme to major disease, also embody and detect and the superiority of warning aspect in major disease based on the early warning system of independent risk combinations of factors examination and method.
As a kind of embodiment, individual essential information comprises name, sex, age and history of disease.When typing individual essential information, name, the sex and age of typing user to be detected, specify that the corresponding relation between blood examination result and user to be measured, and the input of history of disease, the determination for anaphase scheme provides good foundation.
As a kind of embodiment, result output module is medical display.Select special medical display, more complete when blood examination data and personal information when showing, and service life is also longer.
As a kind of embodiment, also comprise print module, the result form obtained from result output module prints by print module.Print module prints receiving from result output module the data come, and more more directly perceived than what show on result output module, also facilitating user to be detected takes the testing result of papery and therapeutic scheme home further treatment simultaneously.And also facilitate the storage of mechanism to user's case to be detected, papery storage is higher than Electronic saving degree of safety.
The present invention is owing to adopting above technical scheme, its technique effect reached is: the early warning system based on the examination of independent risk combinations of factors provided by the invention, break existing hospital routine physical examination finds evening situation to major disease, life-and-death morning is looked into project, with the most convenient, the most feasible mode detects, lower the M & M of major disease, any injury is there is not to client's health in this early warning system and method when detecting, there is good repeatability, both can carry out qualitative when detecting simultaneously, can also carry out quantitatively, and the expense detected detects reduce more than 60% than going hospital and MEC to do a complete set of iconography or blood biochemical analysis, more easily accepted by the common people.
Above-mentioned embodiment is intended to illustrate that the present invention can be professional and technical personnel in the field and realizes or use; modifying to above-mentioned embodiment will be apparent for those skilled in the art; therefore the present invention includes but be not limited to above-mentioned embodiment; any these claims or description of meeting describes; meet and principle disclosed herein and novelty, the method for inventive features, technique, product, all fall within protection scope of the present invention.
Claims (10)
1. based on an early warning system for independent risk combinations of factors examination, it is characterized in that: comprise input module, select module, blood-taking device, blood examination device, data processing module, result treatment module and result output module;
Described input module, for inputting the individual essential information of user to be detected;
Described selection module, selects the blood examination scheme that will carry out for user to be detected;
Described blood-taking device, for gathering the blood of user to be detected;
Described blood examination device, for detecting according to the blood examination scheme selected the user's blood to be detected gathered;
Described data processing module, for receiving the blood examination result that described blood examination device transmits, comparing the reference data of blood examination result in conjunction with individual essential information and pre-stored, comparison result and conclusion is delivered to described result treatment module;
Described result treatment module is used for the comparison result received and conclusion is classified and stores processor, and the result after process is delivered to described result output module and shows.
2. as claimed in claim 1 based on the early warning system of independent risk combinations of factors examination, it is characterized in that: described blood examination device screens the user's blood to be detected gathered, filter out the extreme early mark in blood, by the extreme early mark filtered out respectively with in the blood examination scheme of described selection model choice, the mark in late period combines, and Real-Time Monitoring combine after the change of generation of extreme early mark.
3. as claimed in claim 1 based on the early warning system of independent risk combinations of factors examination, it is characterized in that: the reference data being previously stored with blood examination normal value for different blood examination scheme and blood examination exceptional value in described data processing module, described reference data graphically stores, and draws the conclusion of excessive risk, low-risk or devoid of risk in conjunction with the data that the transmission of described blood examination device comes.
4. as claimed in claim 3 based on the early warning system of independent risk combinations of factors examination, it is characterized in that: in described data processing module, be previously stored with the therapeutic scheme for different risk conclusion, subsidiary corresponding therapeutic scheme while transmitting conclusion to described result treatment module.
5. as claimed in claim 4 based on the early warning system of independent risk combinations of factors examination, it is characterized in that: the data after the personal information of user to be detected and classification store by described data processing module are integrated, and the data after integrating are passed to described result treatment module.
6. as claimed in claim 1 based on the early warning system of independent risk combinations of factors examination, it is characterized in that: in described result treatment module, be pre-stored with clear data form, the therapeutic scheme of the data obtained from described data processing module, conclusion and correspondence is filled into position corresponding in described clear data form by described result treatment module, and is shown by the result Output of for ms after process to described result output module.
7., as claimed in claim 1 based on the early warning system of independent risk combinations of factors examination, it is characterized in that: the blood volume of the user to be detected of collection is 5ml.
8., as claimed in claim 1 based on the early warning system of independent risk combinations of factors examination, it is characterized in that: described individual essential information comprises name, sex, age and history of disease.
9., as claimed in claim 1 based on the early warning system of independent risk combinations of factors examination, it is characterized in that: described result output module is medical display.
10. as claimed in claim 1 based on the early warning system of independent risk combinations of factors examination, it is characterized in that: also comprise print module, the result form obtained from described result output module prints by described print module.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510548703.2A CN105232060A (en) | 2015-08-31 | 2015-08-31 | Early warning system based on independent risk factor combinatory screening |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510548703.2A CN105232060A (en) | 2015-08-31 | 2015-08-31 | Early warning system based on independent risk factor combinatory screening |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105232060A true CN105232060A (en) | 2016-01-13 |
Family
ID=55030090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510548703.2A Pending CN105232060A (en) | 2015-08-31 | 2015-08-31 | Early warning system based on independent risk factor combinatory screening |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105232060A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106599553A (en) * | 2016-11-29 | 2017-04-26 | 中国科学院深圳先进技术研究院 | Disease early-warning method and device |
| CN107038337A (en) * | 2017-03-21 | 2017-08-11 | 广州华康基因医学科技有限公司 | A kind of neonate's Inherited Metabolic Disorders screening method |
| CN108960666A (en) * | 2018-07-19 | 2018-12-07 | 北京凡知医学科技有限公司 | Tumour early stage Risk Evaluating System based on typical experience biomarker |
| CN109887561A (en) * | 2019-02-12 | 2019-06-14 | 北京倍肯恒业科技发展股份有限公司 | A kind of artificial intelligence cervical carcinoma screening determines method and apparatus |
| CN113205872A (en) * | 2021-04-29 | 2021-08-03 | 安徽医科大学第一附属医院 | Intelligent diagnosis and treatment auxiliary system for blood diseases |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102625914A (en) * | 2009-07-29 | 2012-08-01 | 兰多克斯实验室有限公司 | Method for detection of, or the risk of, bladder cancer |
| US20120296621A1 (en) * | 2011-05-20 | 2012-11-22 | University Health Network | Device and method for prediction of acute heart failure mortality |
| CN103119446A (en) * | 2010-06-18 | 2013-05-22 | B.R.A.H.M.S有限公司 | Biomarkers for the prediction of incident cancer |
| CN103582815A (en) * | 2011-02-24 | 2014-02-12 | 佛米利昂公司 | Biomarker panels, diagnostic methods and test kits for ovarian cancer |
| CN104364788A (en) * | 2012-03-05 | 2015-02-18 | 阿克蒂克合伙公司 | Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume |
| WO2015068157A1 (en) * | 2013-11-07 | 2015-05-14 | Medial Research Ltd. | Methods and systems of evaluating a risk of lung cancer |
-
2015
- 2015-08-31 CN CN201510548703.2A patent/CN105232060A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102625914A (en) * | 2009-07-29 | 2012-08-01 | 兰多克斯实验室有限公司 | Method for detection of, or the risk of, bladder cancer |
| CN103119446A (en) * | 2010-06-18 | 2013-05-22 | B.R.A.H.M.S有限公司 | Biomarkers for the prediction of incident cancer |
| CN103582815A (en) * | 2011-02-24 | 2014-02-12 | 佛米利昂公司 | Biomarker panels, diagnostic methods and test kits for ovarian cancer |
| US20120296621A1 (en) * | 2011-05-20 | 2012-11-22 | University Health Network | Device and method for prediction of acute heart failure mortality |
| CN104364788A (en) * | 2012-03-05 | 2015-02-18 | 阿克蒂克合伙公司 | Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume |
| WO2015068157A1 (en) * | 2013-11-07 | 2015-05-14 | Medial Research Ltd. | Methods and systems of evaluating a risk of lung cancer |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106599553A (en) * | 2016-11-29 | 2017-04-26 | 中国科学院深圳先进技术研究院 | Disease early-warning method and device |
| CN106599553B (en) * | 2016-11-29 | 2019-08-16 | 中国科学院深圳先进技术研究院 | Disease Warning Mechanism device |
| CN107038337A (en) * | 2017-03-21 | 2017-08-11 | 广州华康基因医学科技有限公司 | A kind of neonate's Inherited Metabolic Disorders screening method |
| CN108960666A (en) * | 2018-07-19 | 2018-12-07 | 北京凡知医学科技有限公司 | Tumour early stage Risk Evaluating System based on typical experience biomarker |
| CN109887561A (en) * | 2019-02-12 | 2019-06-14 | 北京倍肯恒业科技发展股份有限公司 | A kind of artificial intelligence cervical carcinoma screening determines method and apparatus |
| CN113205872A (en) * | 2021-04-29 | 2021-08-03 | 安徽医科大学第一附属医院 | Intelligent diagnosis and treatment auxiliary system for blood diseases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105232060A (en) | Early warning system based on independent risk factor combinatory screening | |
| Virvidaki et al. | Swallowing and aspiration risk: a critical review of non instrumental bedside screening tests | |
| Aghazadeh-Attari et al. | Association between metabolic syndrome and sensorineural hearing loss: a cross-sectional study of 11,114 participants | |
| Kroep et al. | An accurate cancer incidence in Barrett's esophagus: a best estimate using published data and modeling | |
| Engström et al. | Effectiveness of screening for diabetes mellitus in dental health care | |
| Carneseca et al. | The Hospital de Câncer de Barretos Registry: an analysis of cancer survival at a single institution in Brazil over a 10-year period | |
| CN110840424B (en) | Early warning type in-diagnosis monitoring device and method | |
| Pedersen et al. | Advancing the evaluation of cervical cancer screening: development and application of a longitudinal adherence metric | |
| CN107430645A (en) | The system notified for the laboratory evaluation automated analysis in CICU and risk | |
| Garcia et al. | Risk calculation and periodontal outcomes. | |
| Torabi et al. | Geographical variation and factors associated with colorectal cancer mortality in a universal health care system | |
| CN105611872A (en) | An apparatus and method for evaluating multichannel ECG signals | |
| Nemesure et al. | Will that pulmonary nodule become cancerous? A risk prediction model for incident lung cancer | |
| CN107456209A (en) | Breast cancer early warning system and method for early warning | |
| CN110782990A (en) | Method, system and mobile platform for primary public defense service stroke risk assessment | |
| Sinicrope et al. | Adult daughters' reports of breast cancer risk reduction and early detection advice received from their mothers: an exploratory study | |
| Stegeman et al. | Cancer risk models and preselection for screening | |
| Lundin et al. | Evaluation of a web-based system for survival estimation in breast cancer | |
| CN112331283A (en) | Health monitoring method, device and computer readable medium | |
| CN112233816A (en) | Health monitoring method, device and computer readable medium | |
| CN105852847A (en) | Heart and vital sign monitoring and analyzing system | |
| Virvidaki et al. | Age-specific cutoff scores on a t1-weighted axial medial temporal-lobe atrophy visual rating scale in Alzheimer's disease using clinical research center for dementia of South Korea Data | |
| WO2014203258A1 (en) | Managing medical examinations in a population | |
| CN204351830U (en) | The early stage electro physiology checkout equipment of chronic disease and system | |
| CN104545910A (en) | Method and system for chronic disease early period electrophysiological detection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160113 |